Gynaecomastia in a male patient during stavudine and didanosine treatment for HIV infection

International Journal of STD and AIDS

Volumn 12, Issue 7, 2001, Pages 481-482

  Aquilina, C ^a   Viraben, R ^a  

^a Serv Univ Psychiat l'Enfant l'A   (France)

Author keywords

Gynaecomastia; HIV infection; Nucleoside reverse transcriptase inhibitor

Indexed keywords

DIDANOSINE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG RESPONSE; GYNECOMASTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MALE; PRIORITY JOURNAL;

ADULT; ANTI-HIV AGENTS; DIDANOSINE; GYNECOMASTIA; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; LIPODYSTROPHY; MALE; STAVUDINE;

EID: 0034941106     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462011923390     Document Type: Article

References (8)

1. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy
2. Gynecomastia associated with indinavir therapy
3. Gynecomastia in a male patient during protease inhibitor treatment for acute HIV disease
4. Gynecomastia during indinavir antiretroviral therapy in HIV infection
5. Gynecomastia associated with saquinavir therapy
6. Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection
7. HIV-infection-induced gynecomastia
8. Gynecomastia with stavudine treatment in an HIV-positive patient